交易 ResMed Inc - US - RMD
ResMed (RMD) is a global leader in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD) and other chronic diseases. SDB includes obstructive sleep apnoea (OSA), and other respiratory disorders that occur during sleep. The company’s products and solutions are designed to improve patient quality of life, reduce the impact of chronic disease and lower healthcare costs as global healthcare systems continue to drive a shift in care from hospitals to the home and lower cost settings. ResMed’s cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes and efficiencies for their customers. ResMed employs about 5,000 employees worldwide, operates in 100 countries and has manufacturing facilities in Australia, France, Singapore and the US. The ResMed share price is available at Capital.com.最新股票文章

SpaceX 產業鏈與受惠股:從太空到 AI 再到防務
全面解析 SpaceX 產業鏈:從火箭推進、衛星載荷到地面段,逐一檢視美股、A股與港股受惠標的的功能對標與實際供貨差異,評估估值修復風險與跨市場波動傳導。
07:58, 22 6月 2026

期貨是什麼?一文看懂期貨合約運作、種類與香港交易入門
期貨是什麼?本文拆解期貨合約組成、保證金計算與常見類型(股指、商品、加密貨幣),並詳解香港恒指期貨玩法、開戶流程及風險管理,新手必讀入門教學。
10:57, 16 6月 2026

ETF是什麼?一文讀懂交易所買賣基金的運作、種類與投資方法
ETF是什麼?本文深入解析交易所買賣基金的運作原理、主要類型(指數、債券、主題、槓桿反向)、投資費用及香港/美股熱門ETF清單,幫助新手快速開始ETF投資。
10:21, 16 6月 2026

港人實戰:如何佈局 SpaceX IPO 前後的交易節奏
SpaceX以750億美元完成歷史性IPO,估值1.77萬億美元。深度解析港股CFD交易策略、供應鏈映射與恒生指數聯動,助投資者理解太空經濟相關市場動態。資本面臨風險。
08:58, 16 6月 2026